Zymeworks Inc. Sustainability Profile
Zymeworks Inc., a leading biotechnology company headquartered in the United States, specialises in the development of innovative therapeutic solutions for cancer and other serious diseases. Founded in 2003, Zymeworks has established itself as a pioneer in the field of protein engineering, particularly through its proprietary ZymeLink™ and Zymeworks' Azymetric™ platforms, which enable the creation of multifunctional therapeutics. With a strong presence in North America and expanding operations in Europe and Asia, Zymeworks focuses on advancing its pipeline of bispecific antibodies and antibody-drug conjugates. The company has achieved significant milestones, including strategic partnerships with major pharmaceutical firms, positioning itself as a key player in the biopharmaceutical industry. Zymeworks' commitment to innovation and excellence continues to drive its success in delivering unique, targeted therapies that address unmet medical needs.
DitchCarbon Score
How does Zymeworks Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zymeworks Inc.'s score of 25 is lower than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zymeworks Inc.'s reported carbon emissions
Zymeworks Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Zymeworks Inc. has not established any formal commitments to reduce its carbon footprint or align with industry standards such as the Science Based Targets initiative (SBTi). Without available data or commitments, it is unclear how the company is addressing climate change or its environmental impact. In the context of the biotechnology industry, where many companies are increasingly focusing on sustainability and emissions reduction, Zymeworks Inc. may need to consider developing a comprehensive climate strategy to remain competitive and responsible in its environmental practices.
How Carbon Intensive is Zymeworks Inc.'s Industry?
How Carbon Intensive is Zymeworks Inc.'s Location?
Zymeworks Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zymeworks Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
